Pier P Camplese

Suggest Changes
Learn More
PURPOSE It has been reported that EGFR mutations in lung carcinomas make the disease more responsive to treatment with tyrosine kinase inhibitors. We decided to evaluate the prevalence of EGFR(More)
  • 1